We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.71%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.09B
AUM Growth
+$684M
(+16%)
Cap. Flow
+$419M
Cap. Flow
% of AUM
8.22%
Top 10 Holdings %
Top 10 Hldgs %
29.02%
Holding
1,104
New
355
Increased
287
Reduced
198
Closed
246
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$115M |
| 2 |
Bausch Health
BHC
|
+$84M |
| 3 |
Brookdale Senior Living
BKD
|
+$72M |
| 4 |
Abbott
ABT
|
+$56.3M |
| 5 |
AET
Aetna Inc
AET
|
+$56.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
|
+$160M |
| 2 |
Perrigo
PRGO
|
+$122M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$115M |
| 4 |
Amgen
AMGN
|
+$82M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$36.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 57.19% |
| 2 | Miscellaneous | 8.84% |
| 3 | Consumer Discretionary | 6.01% |
| 4 | Consumer Staples | 5.73% |
| 5 | Utilities | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BDSI
101
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $10M | 0.2% |
1,700,000
+600,000
| +55% | +$3.09M |
|
|
LITS
102
Lite Strategy Inc
LITS
$37.1M
| $9.88M | 0.19% |
61,665
+52,112
| +546% | +$8.91M |
|
103
Medtronic
MDT
$120B
| $9.83M | 0.19% |
171,208
-55,419
| -24% | -$3.14M |
|
|
FEIC
104
DELISTED
FEI COMPANY
FEIC
| $9.81M | 0.19% |
109,783
-50,592
| -32% | -$4.48M |
|
|
ELGX
105
DELISTED
Endologix Inc
ELGX
| $9.69M | 0.19% |
55,542
+8,824
| +19% | +$1.52M |
|
|
SGI
106
Somnigroup International
SGI
$13.8B
| $9.43M | 0.19% |
+698,812
| New | +$8.03M |
|
107
DaVita
DVA
$12.2B
| $9.36M | 0.18% |
147,619
+105,165
| +248% | +$6.17M |
|
|
COLE
108
DELISTED
COLE REAL ESTATE INVESTMENTS, INC COM
COLE
| $9.32M | 0.18% |
+663,888
| New | +$9.05M |
|
109
Conagra Brands
CAG
$7.21B
| $9.28M | 0.18% |
353,807
+96,559
| +38% | +$2.41M |
|
|
STSA
110
DELISTED
STERLING FINL CORP (WA) COM NEW
STSA
| $9.12M | 0.18% |
267,654
+76,389
| +40% | +$2.37M |
|
111
ICU Medical
ICUI
$3.9B
| $9.08M | 0.18% |
142,569
-161,502
| -53% | -$10.4M |
|
|
MJN
112
DELISTED
Mead Johnson Nutrition Company
MJN
| $9.04M | 0.18% |
107,967
+32,206
| +43% | +$2.62M |
|
113
Henry Schein
HSIC
$9.75B
| $8.77M | 0.17% |
195,631
+107,745
| +123% | +$4.71M |
|
114
Flowserve
FLS
$9.03B
| $8.56M | 0.17% |
533,625
+529,975
| +14,520% | +$36.7M |
|
|
YHOO
115
DELISTED
Yahoo Inc
YHOO
| $8.55M | 0.17% |
211,457
+79,276
| +60% | +$2.84M |
|
|
ZLTQ
116
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $8.51M | 0.17% |
+450,000
| New | +$6.43M |
|
117
Melco Resorts & Entertainment
MLCO
$1.76B
| $8.34M | 0.16% |
+212,574
| New | +$7.51M |
|
118
Teleflex
TFX
$5.47B
| $8.27M | 0.16% |
88,149
+32,452
| +58% | +$2.97M |
|
|
EMC
119
DELISTED
EMC CORPORATION
EMC
| $8.22M | 0.16% |
326,751
+96,718
| +42% | +$2.34M |
|
120
Edgewell Personal Care
EPC
$1.23B
| $8.2M | 0.16% |
102,154
+16,466
| +19% | +$1.25M |
|
|
SINA
121
DELISTED
Sina Corp
SINA
| $8.04M | 0.16% |
95,486
+35,459
| +59% | +$2.9M |
|
122
CVS Health
CVS
$121B
| $8.04M | 0.16% |
112,308
-22,079
| -16% | -$1.42M |
|
|
CMCSK
123
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $7.93M | 0.16% |
+158,907
| New | +$7.93M |
|
|
SODA
124
DELISTED
SodaStream International Ltd
SODA
| $7.9M | 0.16% |
159,053
+114,755
| +259% | +$6.53M |
|
125
Burlington
BURL
$14.3B
| $7.88M | 0.15% |
+246,366
| New | +$6.88M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q4 2013 Portfolio in Review
As of Q4 2013, Visium Asset Management held 1,104 positions worth $5.09B, up 16% from $4.41B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Visium Asset Management deployed $419M of net new capital in Q4 2013, opening 355 new positions and adding to 287 existing holdings. Its largest new stake was Bausch Health: 766,970 shares worth $90M.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 55% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $122M trimmed.
- Visium Asset Management's largest Q4 2013 buy was Bausch Health: 766,970 shares worth $90M.
- Visium Asset Management added most to Allergan plc in Q4 2013, an estimated $115M increase.
- Visium Asset Management's biggest Q4 2013 reduction was Perrigo, cutting an estimated $122M.
- Visium Asset Management fully exited WARNER CHILCOTT PLC ORD SHS CL A (IRL) in Q4 2013, selling an estimated $160M.
- Visium Asset Management's ten largest holdings make up 29% of its $5.09B portfolio in Q4 2013.
- Visium Asset Management opened 355 new positions and closed 246 in Q4 2013.
- Visium Asset Management's portfolio value rose 16% quarter-over-quarter to $5.09B.
Based on Visium Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.